BML Capital Management, LLC AVIR Holdings History
BML Capital Management, LLC's Atea Pharmaceuticals Inc Holding Summary
As of 2025-03-31, BML Capital Management, LLC held 7.61 Mil shares of Atea Pharmaceuticals Inc(AVIR), totaling $22.75 Mil. This investment constitutes 18.41% of their stock portfolio, and BML Capital Management, LLC now holds 8.89% of the outstanding Atea Pharmaceuticals Inc(AVIR) stock.
The initial trade took place in 2023Q2. And since then BML Capital Management, LLC has made 8 purchases of AVIR, at an average price of $3.51, for a total of 7.61 Mil shares. Based on historical transaction data and AVIR's current price of $3.46, BML Capital Management, LLC's estimated gain on his AVIR holdings is $-359,687.96, reflecting a -1.35% gain to date.
BML Capital Management, LLC AVIR ($3.46) Holding Chart
BML Capital Management, LLC AVIR ($3.46) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
